The colony-stimulating factors (G-CSF) filgrastim in radiotherapy to decrease the drop-outs for radiogenic leukopenia;Impiego del filgrastim, fattore stimolante le colonie granulocitarie (G-CSF), nella radioterapia allo scopo di ridurne le interruzioni per leucopenie radioindotte

Radiologia Medica

Volumn 95, Issue 3, 1998, Pages 232-236

  Gava, Alessandro ^a   Bertossi, Livio ^a   Ferrarese, Fabio ^a   Coghetto, Francesca ^a   Marazzato, Giorgio ^a   Andrulli, Angela Damiana ^a   Zorat, Pier Luigi ^a  

^a OSPEDALE CA FONCELLO   (Italy)

Author keywords

Filgrastim; Leukopenia; Radiotherapy

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HUMAN; LEUKEMOGENESIS; LEUKOCYTE COUNT; LEUKOPENIA; RADIATION CARCINOGENESIS; RADIATION EXPOSURE;

ADOLESCENT; ADULT; AGED; FEMALE; FILGRASTIM; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; RADIOTHERAPY;

EID: 0031776579     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Adamiez IA, Rosskopf B, Dappler e Coll: Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor. Int J Radiat Oncol Biol Phys 35: 61-67, 1996.
2. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 12: 2471-2508, 1994.
3. Banfi A, Lornbardi F: Danni da radioterapia. In: Bonadonna G, Robustelli Della Cuna G (eds) Medicina oncologica, pag 1331-1342, Masson, Milano, 1994.
4. Bonadonna G, Zucah R, Santoro A e Coll: Combination chemoterapy of Hodgkin's disease with adriamycin, bleomycin vinblastine and imidazole carbozamide versus MOPP. Cancer 36:252-259, 1975.
5. Bonadonna G, Valagussa P, Santoro A. e Coll: Alternating non-cross-resistant combination chemoterapy or MOPP in stage IV Hodgkin's disease. Ann Intern Med 104: 739-746, 1986.
6. Bonadonna G, Valagussa P, Brambilla C, e Coll: Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. Semin Oncol 18:515-524, 1991
7. Brandt SJ, Peters WP, Atwater SK e Coll: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318: 869-876, 1988.
8. Bunn PA, Crowley J, Hazuka M e Coll: The role of GM-CSF in limited stage SCLC: a randomized phase III study of the South-West Oncology Group (SWOG) Proc Am Soc Clin Oncol 11: 292, 1992 (abstr).
9. De Vita VT, Simon RM, Hubbard SM e Coll: Curability of advanced Hodgkin's discase with chemotherapy. Long term follow-up of MOPP treated patients at NCI. Ann Inter Med 92:587-595, 1980.
10. Fowler JF, Lindstrom MJ: Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23: 457-467, 1992
11. Fushiki M, Ono K, Sasai K e Coll: Effect of recombinant human granulocyte colony-stimulating factor on granulocytopenia in mice induced by irradiation Int J Radiat Oncol Biol Phys 18: 353-357, 1990.
12. Gastrointestinal Tumor Study Group: Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10: 549-557, 1992
13. Groopman JE, Molina JM, Scadden DT: Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 321: 1449-1459, 1989.
14. Knox SJ, Fowler S, Marquez C e Coll: Effect of filgrastim (G-CSF) in Hodgkin's disease patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 28: 445-450, 1994.
15. Kodo H, Tajika K, Takahashi S e Coll: Acceleration of neutrophilic granulocyte recovery after bone-marrow transplantation by administration of recombinant human granulocyte colony-stimulating factor. Lancet 2: 38-39, 1988.
16. Kolb HJ: Bone marrow morbidity of radiotherapy. In: Plowman PN, McElwain T, Meadows A (eds) Complications of cancer management, pag 398-411, Butterworth-Heineman, Oxford, England, 1991.
17. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. A review, part 1. N Engl J Med 327: 28-35, 1992
18. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. A review, part 2. N Engl J Med 327: 99-106, 1992.
19. Mac Manus MP, McCormick D, Trimble A e Coll: Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies Eur J Cancer 31A: 302-307, 1995.
20. Marks LB, Friedman H, Kurtzberg J e Coll: Reversal of radiation-induced neutropenia by granulocyte colony-stimulating factor. Med Ped Oncol 20: 240-242, 1992
21. Momin F, Kraut M, Lattin P e Coll Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer (NSCLC) (meeting abstract). Proc Am Soc Clin Oncol 11: P 294, 1992.
22. Morstyn G, Campbell L, Souza LM e Coll: Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet i: 667-672, 1988.
23. Nemunaitis J, Singer JW, Buckner CD e Coll: Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72: 834-836, 1988.
24. Nigro ND. An evaluation of combined therapy for squamous cell of the anal canal. Dis Colon Rectum 27 763, 1984.
25. Plowman PN: The effect of conventional fractionated extended portal radiotherapy on the human peripheral blood count. Int J Radiat Oncol Biol Phys 9 829-839, 1983.
26. Schmidberger H, Hess CF, Hoffmann W e Coll: Granulocyte colony-stimulating factor treatment of leukopenia during fractionated radiotherapy. Eur J Cancer 29A: 1927-1931, 1993.
27. Schuening FG, Storb R, Goehle S e Coll: Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood 74: 1308-1313, 1989.
28. Taylor KM, Jagannath S, Spitzer G e Coll: Recombinant human granulocyte colony stimulating factor hastens granulocyte recovery after high dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease J Clin Oncol 7: 1791-1799, 1989
29. Uckun FM, Gillis S, Souza L e Coll Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. Int J Radiat Oncol Biol Phys 16: 415-435, 1989.
30. Zachanah B: Case Report: role of granulocyte-colony stimulating factor in radiotherapy. Am J Med Sci 304: 252-253, 1992.